Revolutionising Atherosclerosis Treatment
Pantarhin Pharma Inc. introduces BELACT, a biotechnologically produced, dual action like hyaluronidase. This innovative enzyme combines the activities of PH20 and HYAL4 into a single …
Uncategorised
Breaking Down Atherosclerosis Barriers
Pantarhin Pharma Inc. is proud to announce advancements in our novel enzyme, BELACT®. This biotechnologically produced hyaluronidase offers a dual action, combining the functionalities of …
Revolutionizing Atherosclerosis Treatment
Atherosclerosis, a condition characterized by plaque buildup in the arteries, poses a significant threat to cardiovascular health. Current therapies often focus on managing symptoms rather …
Revolutionizing Atherosclerosis Treatment
PANTARHIN PHARMA INC. introduces BELACT®, a biotechnologically produced enzyme with a dual action approach, merging the functionalities of PH20 and HYAL4 into one molecule. This …